Skip to main content
OpenTrials
Completed

NCT Number: NCT03727490

The Role of Subscapularis Repair in Reverse Shoulder Arthroplasty

The overall goal of the study is to determine if repairing the subscapularis tendon during primary reverse shoulder arthroplasty effects short-term patient outcomes. The study is a patient blinded randomized controlled trial that is currently enrolling.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Washington University Department of Orthopaedic Surgery

St Louis, Missouri, 63110, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults undergoing primary reverse shoulder arthroplasty

Exclusion criteria

  • Adults without an intact subscapularis
  • Inflammatory arthritis
  • Revision surgery

Treatment and study plan

Repair

Other

The subscapularis will be repaired.

standard treatment

Other

No repair will be performed

Primary outcomes

  1. American Shoulder and Elbow Surgeons Score

    Time frame: Two Years

    Patient Reported Outcome

Secondary outcomes

  1. Simple Shoulder Test

    Time frame: Two Years

    Patient Reported Outcome

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Registry information

Important dates

Study start
2018
Primary completion
2025
Study completion
2025
First posted
Nov 1, 2018
Registry last updated
Dec 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.